OBIO
USDOrchestra BioMed Holdings Inc. Ordinary Shares
$3.740-0.120 (-3.109%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$3.860
High
$3.950
Low
$3.670
Volume
0.15M
Company Fundamentals
Market Cap
211.2M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.32M
Exchange
NGM
Currency
USD
52-Week Range
Low $2.2Current $3.740High $6.5
Related News
GlobeNewswire
Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial
Orchestra BioMed's Virtue® Sirolimus AngioInfusionTM Balloon ("Virtue SAB") is the first non-coated drug-eluting balloon system designed to deliver a large liquid dose of proprietary extended-release sirolimus
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.